Valute / PRME
PRME: Prime Medicine Inc
4.13
USD
0.17
(4.29%)
Il tasso di cambio PRME ha avuto una variazione del 4.29% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 3.90 e ad un massimo di 4.19.
Segui le dinamiche di Prime Medicine Inc. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
PRME News
- Investing Prime Medicine stock rating reiterated by H.C. Wainwright on CF partnership
- Investing Cystic Fibrosis Foundation expands funding for Prime Medicine
- Investing Prime Medicine chief scientific officer to depart, will serve as consultant
- Seeking Alpha Prime Medicine: Pressing Forward With Lead Liver Targeting Indications (NASDAQ:PRME)
- Investing Prime Medicine stock soars amid gene editing sector momentum
- Benzinga KalVista Pharmaceuticals, Cogent Biosciences, WNS And Other Big Stocks Moving Higher On Monday - Amber International (NASDAQ:AMBR), Baidu (NASDAQ:BIDU)
- Benzinga Hut 8, Greenbrier And Other Big Stocks Moving Higher On Tuesday - Critical Metals (NASDAQ:CRML), Blue Gold (NASDAQ:BGL)
- Investing Prime Medicine shares surge 74% following InvestingPro’s April fair value alert
- Investing Prime Drink Group Announces Launch of Rights Offering
- Investing JMP reiterates Prime Medicine stock rating amid gene editing M&A activity
- Investing Prime Drink Group Provides an Update on Its Bottling Subsidiary Receivershi
- Investing Prime Medicine to Participate in Upcoming Investor Conferences
- Investing Citi cuts Prime Medicine stock rating, slashes target to $1.50
- Benzinga This MongoDB Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - ATI (NYSE:ATI), MongoDB (NASDAQ:MDB)
- Investing Prime Medicine stock target cut to $6 by JMP Securities
- Investing JPMorgan cuts Prime Medicine stock rating to neutral
- Investing Chardan cuts Prime Medicine stock target to $12, maintains Buy
- Investing Jefferies cuts Prime Medicine stock target to $9, maintains Buy
- Investing Citi maintains Prime Medicine stock with $10 target
- Investing Prime Medicine stock plummets amid restructuring and leadership changes
- Investing Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease
- Investing Prime Medicine refocuses on liver disease, leadership changes
- The Motley Fool Why Prime Medicine Stock Was Climbing Higher This Week
- The Motley Fool Why Prime Medicine Stock Is Soaring Today
Intervallo Giornaliero
3.90
4.19
Intervallo Annuale
1.11
5.63
- Chiusura Precedente
- 3.90
- Apertura
- 3.96
- Bid
- 4.13
- Ask
- 4.43
- Minimo
- 3.90
- Massimo
- 4.19
- Volume
- 8.640 K
- Variazione giornaliera
- 4.29%
- Variazione Mensile
- 70.66%
- Variazione Semestrale
- 52.96%
- Variazione Annuale
- -26.38%
20 luglio, domenica